Literature DB >> 33776902

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.

Weiwei Liang1, Fangfang Sun2.   

Abstract

Background: This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.
Methods: The alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model.
Results: One thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1- and 3-year survival rate.
Conclusion: Our data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.
Copyright © 2021 Liang and Sun.

Entities:  

Keywords:  AUC; adrenocortical carcinoma; alternative splicing; bioinformatics; prognostic model

Mesh:

Substances:

Year:  2021        PMID: 33776902      PMCID: PMC7994755          DOI: 10.3389/fendo.2021.538364

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  45 in total

1.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

Review 2.  The role of alternative splicing in cancer drug resistance.

Authors:  Zahava Siegfried; Rotem Karni
Journal:  Curr Opin Genet Dev       Date:  2017-11-05       Impact factor: 5.578

3.  Prognostic parameters of metastatic adrenocortical carcinoma.

Authors:  Guillaume Assié; Guillemette Antoni; Frédérique Tissier; Bernard Caillou; Gwenaelle Abiven; Christine Gicquel; Sophie Leboulleux; Jean-Paul Travagli; Clarisse Dromain; Xavier Bertagna; Jérôme Bertherat; Martin Schlumberger; Eric Baudin
Journal:  J Clin Endocrinol Metab       Date:  2006-10-24       Impact factor: 5.958

4.  In-depth mining of clinical data: the construction of clinical prediction model with R.

Authors:  Zhi-Rui Zhou; Wei-Wei Wang; Yan Li; Kai-Rui Jin; Xuan-Yi Wang; Zi-Wei Wang; Yi-Shan Chen; Shao-Jia Wang; Jing Hu; Hui-Na Zhang; Po Huang; Guo-Zhen Zhao; Xing-Xing Chen; Bo Li; Tian-Song Zhang
Journal:  Ann Transl Med       Date:  2019-12

Review 5.  Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer.

Authors:  Merve Aksoz; Raife Dilek Turan; Esra Albayrak; Fatih Kocabas
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

6.  The Functional Impact of Alternative Splicing in Cancer.

Authors:  Héctor Climente-González; Eduard Porta-Pardo; Adam Godzik; Eduardo Eyras
Journal:  Cell Rep       Date:  2017-08-29       Impact factor: 9.423

7.  Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.

Authors:  Tobias Else; Andrew R Williams; Aaron Sabolch; Shruti Jolly; Barbra S Miller; Gary D Hammer
Journal:  J Clin Endocrinol Metab       Date:  2013-12-03       Impact factor: 5.958

8.  Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.

Authors:  Yingbin Huang; Guangyu Chen; Yang Wang; Rui He; Jun Du; Xingyuan Jiao; Qiang Tai
Journal:  Biochem Biophys Res Commun       Date:  2018-08-02       Impact factor: 3.575

9.  MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.

Authors:  Xueyuan Tang; Long Jin; Peiguo Cao; Ke Cao; Chenghui Huang; Yanwei Luo; Jian Ma; Shourong Shen; Ming Tan; Xiayu Li; Ming Zhou
Journal:  Oncotarget       Date:  2016-04-26

10.  Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.

Authors:  Rui Huang; Xiwen Liao; Qiaochuan Li
Journal:  Onco Targets Ther       Date:  2017-11-02       Impact factor: 4.147

View more
  2 in total

1.  Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases.

Authors:  María Ángeles Peinado; David Ovelleiro; María Luisa Del Moral; Raquel Hernández; Esther Martínez-Lara; Eva Siles; José Rafael Pedrajas; María Luisa García-Martín; Carlos Caro; Sebastián Peralta; María Encarnación Morales; María Adolfina Ruiz; Santos Blanco
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

2.  Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer.

Authors:  Mian Liu; Rooh Afza Khushbu; Pei Chen; Hui-Yu Hu; Neng Tang; Deng-Jie Ou-Yang; Bo Wei; Ya-Xin Zhao; Peng Huang; Shi Chang
Journal:  Front Oncol       Date:  2021-10-13       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.